HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gregory J Gores Selected Research

Cholangiocarcinoma

1/2022FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations.
8/2021DNA Methylation Markers for Detection of Cholangiocarcinoma: Discovery, Validation, and Clinical Testing in Biliary Brushings and Plasma.
1/2021MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma.
12/2020The Hippo Pathway and YAP Signaling: Emerging Concepts in Regulation, Signaling, and Experimental Targeting Strategies With Implications for Hepatobiliary Malignancies.
5/2020An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort.
1/2020Endoscopic Ultrasound/Fine Needle Aspiration Is Effective for Lymph Node Staging in Patients With Cholangiocarcinoma.
1/2020Systemic therapies for intrahepatic cholangiocarcinoma.
1/2020Cholangiocarcinoma 2020: the next horizon in mechanisms and management.
10/2019Immunobiology of cholangiocarcinoma.
2/2019Hedgehog Signaling Modulates Interleukin-33-Dependent Extrahepatic Bile Duct Cell Proliferation in Mice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gregory J Gores Research Topics

Disease

85Neoplasms (Cancer)
04/2022 - 03/2002
84Cholangiocarcinoma
01/2022 - 03/2002
36Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2003
27Fibrosis (Cirrhosis)
01/2020 - 07/2003
26Sclerosing Cholangitis
01/2022 - 05/2002
26Klatskin Tumor
08/2021 - 10/2002
24Non-alcoholic Fatty Liver Disease
01/2022 - 02/2002
23Inflammation (Inflammations)
01/2021 - 03/2002
23Liver Diseases (Liver Disease)
01/2021 - 06/2003
16Carcinogenesis
01/2020 - 04/2002
13Pathologic Constriction (Stenosis)
11/2017 - 03/2004
10End Stage Liver Disease
01/2021 - 09/2006
10Cholestasis
01/2018 - 11/2002
9Neoplasm Metastasis (Metastasis)
09/2016 - 05/2004
8Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2022 - 05/2004
8Infections
01/2020 - 09/2003
8Necrosis
01/2018 - 02/2002
7Fatty Liver
10/2020 - 09/2005
7Leukemia
01/2020 - 07/2006
7Mitochondrial Diseases (Mitochondrial Disease)
01/2013 - 02/2002
6Alcoholic Hepatitis
01/2021 - 08/2003
6Liver Neoplasms (Liver Cancer)
01/2019 - 10/2010
5Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2022 - 05/2002
5COVID-19
11/2021 - 12/2020
5Hepatitis C
01/2021 - 10/2005
5Glioma (Gliomas)
02/2019 - 03/2011
5Insulin Resistance
09/2017 - 11/2008
4Liver Cirrhosis (Hepatic Cirrhosis)
11/2021 - 09/2006
4Obesity
11/2020 - 10/2016
4Hepatitis
01/2020 - 02/2002
4Aneuploidy (Aneuploid)
01/2019 - 03/2004
3Disease Progression
05/2016 - 05/2004
3Residual Neoplasm
04/2016 - 12/2006
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2013 - 03/2002
2Hematologic Neoplasms (Hematological Malignancy)
04/2022 - 09/2013
2Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2022 - 06/2003

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2002
19Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020 - 11/2002
18Biomarkers (Surrogate Marker)IBA
11/2021 - 09/2006
18LigandsIBA
10/2020 - 11/2002
116-propylchromone-2-carboxylic acid (PCCA)IBA
11/2020 - 12/2013
11CytokinesIBA
01/2020 - 02/2004
9Interleukin-6 (Interleukin 6)IBA
03/2021 - 02/2004
9CaspasesIBA
03/2016 - 03/2003
9Death Domain ReceptorsIBA
01/2015 - 03/2002
9Nonesterified Fatty Acids (NEFA)IBA
04/2013 - 04/2006
8Bile Acids and Salts (Bile Acids)IBA
01/2021 - 04/2002
7Messenger RNA (mRNA)IBA
04/2022 - 03/2004
7Pharmaceutical PreparationsIBA
01/2021 - 12/2004
7Phosphotransferases (Kinase)IBA
11/2020 - 04/2002
74- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
05/2012 - 03/2004
6LipidsIBA
11/2020 - 09/2005
5DNA (Deoxyribonucleic Acid)IBA
08/2021 - 03/2004
5Protein Kinases (Protein Kinase)IBA
01/2020 - 12/2004
5EnzymesIBA
12/2013 - 04/2002
5Cathepsin BIBA
05/2008 - 07/2003
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2004 - 03/2002
4BilirubinIBA
01/2022 - 08/2009
4VaccinesIBA
11/2021 - 01/2021
4Biological ProductsIBA
08/2021 - 08/2011
4Fatty Acids (Saturated Fatty Acids)IBA
10/2020 - 02/2002
4TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
10/2020 - 11/2011
4Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
12/2018 - 04/2016
4TNF-Related Apoptosis-Inducing LigandIBA
09/2017 - 05/2007
4MicroRNAs (MicroRNA)IBA
01/2017 - 05/2009
4Small Interfering RNA (siRNA)IBA
01/2013 - 11/2003
3Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
01/2022 - 08/2014
3ParaffinIBA
08/2021 - 10/2012
3Formaldehyde (Formol)FDA Link
08/2021 - 10/2012
3Antiviral Agents (Antivirals)IBA
01/2021 - 10/2016
3Alkaline PhosphataseIBA
05/2020 - 04/2016
3CholesterolIBA
01/2020 - 05/2002
3Adenosine Monophosphate (AMP)IBA
01/2020 - 12/2011
3Interleukin-33IBA
02/2019 - 07/2014
3InterleukinsIBA
02/2019 - 06/2005
3Immunoglobulin A (IgA)IBA
01/2017 - 05/2004
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2017 - 03/2007
33- (2- (2- tert- butylphenylaminooxalyl)aminopropionylamino)- 4- oxo- 5- (2,3,5,6- tetrafluorophenoxy)pentanoic acidIBA
03/2015 - 03/2003
3CXC ChemokinesIBA
03/2015 - 07/2003
3Metformin (Glucophage)FDA LinkGeneric
11/2014 - 02/2013
3Sorafenib (BAY 43-9006)FDA Link
11/2014 - 10/2005
3CarbohydratesIBA
03/2014 - 09/2012
3Transcription Factors (Transcription Factor)IBA
10/2013 - 08/2009
3AntibodiesIBA
09/2010 - 05/2004
3Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2008 - 03/2002
3Adenosine Triphosphate (ATP)IBA
02/2006 - 02/2002
3ErbB Receptors (EGF Receptor)IBA
11/2004 - 04/2002
2Indicators and Reagents (Reagents)IBA
03/2021 - 08/2009
2FructoseIBA
01/2020 - 09/2017

Therapy/Procedure

56Therapeutics
04/2022 - 01/2003
46Liver Transplantation
01/2021 - 10/2002
17Neoadjuvant Therapy
11/2020 - 05/2004
15Transplantation
05/2017 - 02/2003
10Drug Therapy (Chemotherapy)
04/2022 - 09/2006
5Radiotherapy
10/2020 - 08/2011
4Ligation
01/2016 - 07/2003
3Immunotherapy
01/2021 - 10/2010
3Stents
01/2013 - 08/2006
3Cholecystectomy
09/2012 - 05/2002
2Precision Medicine
04/2020 - 09/2015